Company ProfilePremium

Sunrakshakk Industries India Limited (formerly A.K. Spintex Limited)

Company Profile Analysis

Tickers: SUNRAKSHAK.NS, 539300.BO

ESOMAR 23 Corporate BadgeISO Certifications Badge
Sunrakshakk Industries India Limited - Company showcase

Year Founded & Workforce

1994

Sunrakshakk Industries India Limited logo

Sunrakshakk Industries India Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Sunrakshakk Industries India Limited Overview

Sunrakshakk Industries India Limited is a Bhilwara-based micro-cap that is in the middle of a fast transformation. For about three decades, as A.K. Spintex, it ran a job-work process house that dyed, printed and finished polyester and cotton grey fabric for the Bhilwara textile cluster, with revenue around ₹50–120 crore. In December 2024 it acquired a related-party business, Sunrakshak Agro Products Pvt. Ltd., and changed its name. It then raised about ₹98.65 crore through a preferential issue and used it to acquire manufacturing assets in Bhilwara (edibles) and Guwahati (soap noodles and cosmetics). The company is now mainly a B2B contract and intermediate manufacturer of soap noodles, toilet soaps, detergents, toothpaste, cosmetics, home-care products and packaged savouries/spices. It runs five FMCG plants and one fabric plant across Rajasthan, Uttarakhand and Assam. FY2026 consolidated revenue was ₹607.75 crore, up 237% year on year. Q1 FY27 revenue was ₹276.33 crore, of which about 90.6% came from FMCG. Management targets about ₹1,000 crore of revenue by FY2028.


What the company does

The company now has two operating businesses. Third-party profiles such as Simply Wall St also describe two segments, "Textiles" and "FMCG".

  1. Textile processing (legacy). The company processes synthetic (polyester) and cotton grey fabric, including dyeing, printing and finishing, mostly on a job-work basis. That means the customer, typically a weaver or fabric trader in the Bhilwara cluster, owns the grey fabric and pays a processing charge. The finishing range includes a Comfit finish range and a fully automatic Yamuna hydraulic jigger (both added in FY2015) and a set brushing/sueding machine (added in FY2017). Disclosed processing capacity is 45 lakh metres per month (company investor deck). CRISIL's rationale cites 48 lakh metres per month from older information. Processed volume in FY2026 was 5.10 crore metres (Q1 FY27 deck).

  2. FMCG, FMCG intermediates and edibles (new since Jan 2025). This business manufactures:

    • FMCG intermediates: mainly soap noodles, the base input that soap brands buy and then perfume, mill and stamp into bars.

    • Personal care: toilet/bath soap, toothpaste and cosmetics.

    • Home care: detergent powder/bars, cleaners and other home-care products. Plastic moulding products are also mentioned in the Q2 FY26 deck.

    • Edibles: savouries (Sun Papsi, Majedar Bhujia, coated peanuts, packed ghee) and spices (Rasoi Tadaka Masala, red chilli, turmeric and coriander powders).

Business model and revenue model

DimensionCharacterisation
Product vs. service mixTextile: a service model (job-work processing fees). FMCG: a product model (manufactured goods sold B2B). Edibles: products, some under in-house names.
Subscription / licensing—
B2B vs. B2COn the Q1 FY27 call (Aug 2026), management said revenue is "basically B2B" and the company does not operate in B2C. Edible SKUs carry names such as "Sun Papsi", but the company does not describe itself as running a consumer brand business.
Customer count200+ customers (Q2 FY26 and Q1 FY27 decks)
Customer typesTextile: Bhilwara-cluster weavers, fabric traders and suiting/shirting converters. FMCG: soap and detergent brand owners, FMCG marketers and distributors. Edibles: distributors and retail channels. No customers are named publicly.
End-marketsDomestic Indian textiles (suiting/shirting fabrics); Indian FMCG (personal care, home care); packaged foods
GeographyEssentially India only. No export revenue is disclosed.

Value-chain position

In textiles, the company sits in the mid-stream processing stage, between weaving and garmenting. It earns a conversion margin and carries limited raw-material risk because it does not own the fabric, although it does buy dyes, chemicals and boiler fuel. In FMCG, it sits upstream of consumer brands. As a soap-noodle supplier it is a chemical-intermediate converter, buying oils/fatty acids and caustic soda. As a finished-goods contract manufacturer it competes on cost, capacity and proximity to customers' markets. This position gives lower gross margins than branded FMCG players, but it needs less spending on advertising and distribution.

The company's own description and independent characterisation

In its 22 May 2025 press release and FY2026 Annual Report, the company describes itself as a diversified enterprise. It says textiles remain an important foundation, while future growth is anchored in FMCG and FMCG-intermediate chemicals. The FY2026 chairman's letter says FMCG contributed about 82% of FY2026 revenue, compared with 42% in FY2025, and that FMCG revenue crossed ₹500 crore.

Independent characterisation: In substance, Sunrakshakk is now a small-ticket B2B FMCG contract and intermediate manufacturer, with a legacy textile job-work unit attached. Its economics look more like a B2B manufacturing platform such as Hindustan Foods (EBITDA margin around 8–9%) than like a branded FMCG company such as Jyothy Labs (operating margin around 13–14%). Q1 FY27 consolidated EBITDA margin was 8.18%, and FMCG segment EBITDA margin was 8.55%. Growth has come mainly from acquiring and commissioning capacity: SAPPL, the Bhilwara food facility, the Guwahati plant and the Roorkee soap line. The investment case now rests on raising utilisation from the current 50–55%, and on whether management can keep margins steady through crude-linked input volatility.

Strategy

Stated strategy themes (paraphrased from FY2026 Annual Report and investor decks)

Change the revenue mix toward FMCG: Make FMCG, FMCG intermediates and edibles the growth engine, with textile falling to about 8–10% of revenue over the long term (Q1 FY27 concall).

  • Scale through acquired and commissioned capacity, then sweat the assets. Capacity build-out is largely complete. Management does not expect much incremental capacity capex for the next 12–18 months, and the focus moves to raising utilisation from 50–55% (Q1 FY27 concall).

Build a multi-location manufacturing network: Plants in Bhilwara (West/North), Roorkee (North) and Guwahati (East/North-East) aim to cut freight costs and add supply-chain flexibility.

Deepen distribution and channels; optimise manufacturing: This is the "Way Ahead" slide of the Q4 FY26 deck.

Allocate capital prudently: No new fundraise is planned. The company intends to keep working capital from scaling in proportion to revenue.

Strategic initiatives in the last 24 months

InitiativeDateDetailStatus
Amend objects for the FMCG forayOct 2024MoA amended to cover cosmetics, personal/home/plant/pet care, packaging and intermediatesDone
SAPPL acquisition27 Dec 2024100% of a related-party FMCG/intermediates makerIntegrated; consolidated from 1 Jan 2025
RebrandingApr–May 2025Name change, scrip ID change, website migration (Feb 2026)Done
Preferential equity raiseMar–Jul 202511,69,600 shares at ₹840 (about ₹98 crore)Allotted 30 May 2025
Bhilwara food facility acquisition2,025Savouries and spices; fully operational Sep 2025Ramping; single shift
Guwahati plant acquisition and commissioningLate 2025 → 8 Jan 2026Soap noodles 2,160 TPM plus cosmetics 1,000 TPMRamping (₹63.9 crore in Q1 FY27)
Roorkee soap lineQ1 FY27+1,700 TPM toilet soapCommissioned
Stock splitOct 20251:5, to improve liquidityDone
Investor communication programmeJun 2025 onwardQuarterly decks and earnings calls with recordingsOngoing

Management targets and guidance

TargetSource / dateDetail
Revenue about ₹1,000 crore by FY2028Q2 FY26 deck (Nov 2025); reiterated through Q1 FY27About 90% from FMCG
Revenue CAGR 30–35% over FY2025–FY2029Q2 FY26 / Q4 FY26 decksDirectional
FY2027 revenue ₹900–1,000 croreQ1 FY27 concall (Aug 2026)This pulls the ₹1,000 crore aspiration forward by about a year
FY2028 revenue growth of 15–20% over FY2027Q1 FY27 concallImplies about ₹1,035–1,200 crore
PAT margin about 6% in FY2027, improving 0.75–1.0 pp in FY2028Q1 FY27 concallAn earlier deck cited 7% PAT margin by FY2028
Return on capital deployed 28–30% (run-rate)Q4 FY26 / Q1 FY27 decksCompany's own calculation on ₹98.65 crore raised
No fresh fundraiseQ1 FY27 concallCurrent stance

ESG or sustainability commitments: none disclosed. Formal cost programmes: none disclosed.

Products & Services

Textile segment

OfferingDescription / specificationsTarget customerLaunch / latestPricing model
Polyester fabric processingDyeing and finishing of synthetic grey fabric (suiting/shirting) on job-workBhilwara weavers and tradersSince 1995Per-metre job-work charge (rates not disclosed)
Cotton fabric processingDyeing, printing and finishing of cotton grey fabricSameSince 1995Job-work
PrintingFabric printing servicesSame—Job-work
Value-added finishesComfit finish (FY2015), hydraulic jigger dyeing (FY2015), sueding/brushing (FY2017)Premium suiting convertersFY2015–FY2017Job-work
Capacity45 lakh metres/month (company); 48 lakh m/month (CRISIL, older data)———
Volume5.10 crore metres processed in FY2026———

FMCG intermediates

ProductPlantMonthly capacity (MT)DescriptionCustomerStatus
Soap noodlesRoorkee5,760Base soap pellets for toilet and laundry soap makers; the largest revenue line (₹87.62 crore in Q1 FY27)Soap brand owners and contract soap makersOperating
Soap noodlesGuwahati2,160Same; serves the North-East and eastern marketsSameCommissioned 8 Jan 2026

FMCG finished products (personal and home care)

ProductPlantMonthly capacity (MT)Notes
Toilet/bath soapRoorkee3,000 (+1,700 new line in Q1 FY27)₹27.50 crore revenue in Q1 FY27. The website lists "Bath Soap" as a focus product.
ToothpasteRoorkee500Listed as a new business vertical in the Q2 FY26 deck
Cosmetics / personal careGuwahati1,000₹26.15 crore revenue in Q1 FY27
Detergent (powder/bar)Bhilwara3,500Detergent bars were a core SAPPL line at acquisition
Home care (cleaners etc.)Bhilwara1,200₹3.49 crore in Q2 FY26 per deck
Plastic moulding products——Mentioned in the Q2 FY26 deck and in Simply Wall St's profile

Edibles

CategoryNamed SKUs (per Q4 FY26 deck)Plant / capacityCommissioned
SavouriesSun Papsi; Majedar Bhujia; coated peanuts; ghee (pack)Bhilwara; savouries 850 TPM (total edibles 2,500 TPM)Fully operational Sep 2025
SpicesRasoi Tadaka Masala; red chilli powder; turmeric powder; coriander powderBhilwara; spices 650 TPMSep 2025

The edibles plant runs one shift, and management has said a second shift is available, giving room to grow without new capex (Q1 FY27 concall). Pricing is not disclosed for any product line.

Aggregate capacity

Capacity metricQ2FY26Q4FY26Q1FY27
FMCG and intermediates capacity (MT per month)15,48019,64020,840
Textile processing capacity (lakh metres per month)454545

Note: the section-wise capacities sum to 19,620 MT before the new soap line. Adding 1,700 MT should give about 21,320 MT, but the company reports 20,840 MT. This gap of about 480 MT has not been explained. Overall utilisation is 50–55% (Q1 FY27 concall).

Financial Narrative

FY2022–FY2024 are standalone (pure textile). FY2025 consolidates one quarter of SAPPL. FY2026 is the first full consolidated year. Sources: Screener.in (C-MOTS data from BSE filings); company investor decks for FY2025 and FY2026 revenue, EBITDA and PAT; CRISIL KFI table for FY2026. Screener rounds to whole crores, so ratios computed from those figures are approximate.

Income statement (INR crore)

Diluted EPS equals basic EPS because no convertibles are disclosed.

Margins (%)

Revenue CAGR FY2022–FY2026: about 70% ((607.75/73)^(1/4) − 1). Excluding acquisition effects, the textile business grew from ₹73 crore to about ₹109 crore, a CAGR of about 10%.

Commentary.

FY2023 was the first inflection: Textile revenue jumped 59% as post-COVID cluster demand recovered, and EBITDA margin expanded 400 bps to 14% on operating leverage.

FY2024: was flat on revenue (₹117 crore), but EBITDA margin rose to 16% as costs eased.

FY2025: contains a textile decline to about ₹104.5 crore, offset by ₹75.7 crore of FMCG revenue from one quarter of SAPPL.

FY2026 is the transformation year: Revenue more than tripled, but EBITDA margin compressed to 9.66% because the mix shifted to lower-margin B2B FMCG. Management explicitly says FY2026 ratios are not comparable with FY2025.

Quarterly EBITDA margin then ran at 9.28% (Q1 FY26), 9.65% (Q2), 9.31% (Q3), 10.19% (Q4) and 8.18% (Q1 FY27). The Q1 FY27 dip reflected crude-linked raw-material inflation (LABSA, dyes, chemicals, boiler fuel). Gross profit is not separately disclosed in the sources reviewed.

Quarterly trajectory (consolidated, INR crore)

Q2 FY26 EBITDA is derived as FY2026 total minus the other three quarters. Q2 and Q3 PAT are derived from Google Finance EBT and tax data and reconcile to the FY2026 total of ₹34.98 crore. Company decks report Q1 FY26 EPS as ₹2.41, while Screener shows ₹2.10, because of different share-count bases. TTM to Q1 FY27: revenue about ₹759 crore and PAT about ₹43.5 crore (Screener).

Balance sheet (INR crore, as at 31 March)

Net debt cannot be computed precisely because year-end cash is not disclosed in the sources reviewed. Aggregator data suggests cash is small, in the single-digit crores. On that basis, net debt in FY2026 is probably close to gross debt of about ₹47 crore. Goodwill from the SAPPL acquisition is not separately disclosed in the sources reviewed.

Commentary. The balance sheet stayed tiny and conservative through FY2024, with debt/equity of 0.18. FY2025 shows the acquisition footprint. Standalone investments rose from ₹0 to ₹25 crore, which is consistent with the cost of acquiring SAPPL, although the exact consideration is not disclosed. Standalone borrowings rose from ₹7 crore to ₹41 crore, which suggests the deal was largely debt-funded; this is an inference. In FY2026 the preferential issue of about ₹98 crore lifted reserves from ₹47 crore to ₹179 crore. That capital went into fixed assets (up ₹40 crore) and, more significantly, into working capital (other assets up ₹122 crore).

Cash flow (INR crore)

Commentary. Cash conversion is the most important red flag in the financial profile. The textile business historically converted 84–128% of EBITDA into operating cash, helped by negative cash-conversion cycles because it held customer fabric and paid suppliers slowly. After the FMCG pivot, CFO collapsed to roughly zero in FY2025 and to −₹34 crore in FY2026, despite ₹58.7 crore of EBITDA. Standalone CFO was −₹66 crore. The cumulative two-year FCF deficit of about ₹113 crore was financed by the preferential issue and new debt. Screener also flags that the company "might be capitalising interest cost". Management says it intends to keep working capital from rising in proportion to revenue. Proof of that would be the main validation event for FY2027.

Ratios

ROE, ROA and asset turnover are computed on average balances from rounded Screener figures. ROCE and working-capital metrics are Screener-reported (standalone FY2022–FY2024, consolidated FY2025–FY2026). Interest is rounded to ₹1 crore in early years, so coverage ratios are indicative only. Net debt/EBITDA is shown as gross debt/EBITDA because cash is not disclosed.

Commentary. Returns are high on paper: about 30% ROE and 29% ROCE in FY2026. However, they sit alongside negative operating cash flow, which points to earnings that are not yet backed by cash. The cash-conversion cycle swung from −40 days to +31 days. Payable days collapsed from 264 to 72, so the supplier credit that funded the textile business is not available in FMCG, where commodity inputs are bought on short terms. At standalone level, working-capital days ballooned from 22 to 161. Leverage is low (0.25x D/E; about 0.8x debt/EBITDA), and interest cover is comfortable at about 15x.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipBusinessNotes

Sunrakshakk Industries India Ltd

Listed parent

Textile processing (Bhilwara); also owns the Bhilwara edibles facility and the Guwahati plant, both acquired with preferential-issue proceeds

Standalone FY2026 revenue ₹214 crore

Sunrakshak Agro Products Pvt. Ltd. (SAPPL)

Wholly owned subsidiary since 27 Dec 2024

FMCG products and intermediate chemicals (detergent bars, home care, personal care, soap noodles)

Authorised capital ₹2 crore. Consolidation adds about ₹394 crore of FY2026 revenue (consolidated ₹608 crore minus standalone ₹214 crore).

Revenue by Segment and Revenue by Segment (%)

SegmentFY2024FY2025FY2026

Textile processing revenue (INR Cr)

117104.5109

FMCG incl. intermediates and edibles revenue (INR Cr)

075.7498

Total revenue from operations (INR Cr)

117180.16607.75

Textile share of revenue (%)

1005818

FMCG share of revenue (%)

04282

Revenue by Segment

SegmentQ4FY26Q1FY27

FMCG revenue (INR Cr; Q4FY26 label-corrected)

170.79250.10

Textile revenue (INR Cr; Q4FY26 label-corrected)

26.8026.23

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment by Location / Section

Location / sectionQ4FY26Q1FY27

Roorkee soap section (INR Cr)

17.6327.50

Roorkee noodle section (INR Cr)

44.4787.62

Bhilwara home care and detergent (INR Cr)

32.5040.98

Bhilwara edibles (INR Cr)

29.2630.34

Guwahati cosmetics (INR Cr)

20.9126.15

Guwahati noodle section (INR Cr)

26.0137.75

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

73116117180.16607.75

EBITDA (INR Cr)

7161925.6658.69

Depreciation (INR Cr)

4671114

Operating income EBIT approx (INR Cr)

310121545

Other income (INR Cr)

00013

Interest expense (INR Cr)

11113

Pre-tax income (INR Cr)

39111444

Net income (INR Cr)

1.87.38.411.0134.98

EPS basic (INR, split-adjusted)

0.722.903.354.3711.28

EPS diluted (INR, split-adjusted)

0.722.903.354.3711.28

Dividend per share (INR)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

EBITDA margin (%)

10141614.249.66

Operating EBIT margin (%)

4.18.610.38.27.4

Net margin (%)

2.56.37.26.115.76

Effective tax rate (%)

3322262221

Income Statement and Margin Analysis (%)

MetricQ4FY25Q1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue (INR Cr)

102.74125.24120.97163.95197.59276.33

EBITDA (INR Cr)

11.4011.6211.6715.2620.1422.59

EBITDA margin (%)

11.099.289.659.3110.198.18

PAT (INR Cr)

6.446.526.959.4112.1015.04

PAT margin (%)

6.275.215.755.746.125.44

EPS basic (INR)

2.562.412.243.033.904.85

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

526068158324

Net fixed assets (INR Cr)

25283861101

Capital work in progress (INR Cr)

000711

Total borrowings (INR Cr)

111074347

Shareholders equity (INR Cr)

23303952185

Equity share capital (INR Cr)

55556

Other assets mainly current (INR Cr)

28323090212

Other liabilities mainly current (INR Cr)

1819226492

Approx net working capital (INR Cr)

1013826120

Cash Flow and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Cr)

711210-34

Investing cash flow (INR Cr)

-8-9-18-27-56

Financing cash flow (INR Cr)

1-2-43399

Capex derived (INR Cr)

89172158

Free cash flow (INR Cr)

-124-21-92

Dividends paid (INR Cr)

00000

Buybacks (INR Cr)

00000

CFO to EBITDA (%)

1058412813-43

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE (%)

828242430

ROA (%)

3.613.013.29.714.5

ROCE (%)

1128282229

Debt to equity (x)

0.480.330.180.830.25

Gross debt to EBITDA (x)

1.60.60.41.70.8

Interest coverage EBIT to interest (x)

310121515

Asset turnover (x)

1.52.11.81.62.5

Debtor days

7662537330

Inventory days

17410110915173

Payable days

30020225426472

Cash conversion cycle (days)

-49-38-92-4031

Working capital days

252191654

Revenue by Region

RegionFY2024FY2025FY2026

India revenue (INR Cr)

117180.16607.75

Production state

Production statePlant(s)Segment(s)Q1 FY27 revenue (INR Cr)Share of Q1 FY27 revenue

Uttarakhand (Roorkee)

Soap, noodle and toothpaste plant

FMCG

115.1241.7%

Rajasthan (Bhilwara)

Home care/detergent; edibles; textile process house

FMCG + Textile

97.55 (71.32 FMCG + 26.23 textile)

35.3%

Assam (Guwahati)

Soap noodles + cosmetics

FMCG

63.9023.1%

Valuation Snapshot

MetricValueSource

Last close

₹364 (16 Oct 2026)

Screener

52-week high / low

₹394 / ₹201

Screener

1-year return

+41%

Screener

3-year price CAGR

143% (about 14x)

Screener

5-year price CAGR

134%

Screener

10-year price CAGR

41%

Screener

Market cap

About ₹1,127 crore

Screener

Liquidity

Thinly traded. BSE group "X". Daily volumes are typically a few thousand shares (e.g., 3,880 on 4 Sep 2026).

Accord Fintech; Google Finance

Share Price

Price pointApr2024Nov2024Dec2024Jan2026Oct2026

Share price split-adjusted (INR)

30.774.1148.0207.5364.0

Valuation Multiples

MultipleSunrakshakkBanswara Syntex

P/E trailing (x)

25.923.4

EV/EBITDA trailing (x)

16.7—

EV/Sales trailing (x)

1.5—

P/B (x)

6.10.8

Capital Markets

MetricFY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

00000

Dividend payout (%)

00000

Buyback (INR Cr)

00000

Action by Date

DateActionDetail

30 May 2025

Preferential allotment

11,69,600 shares at ₹840 (₹10 face value + ₹830 premium) to promoter and non-promoter groups. Gross proceeds: about ₹98.25 crore by arithmetic; the company cites ₹98.65 crore raised; the EGM approval cap was ₹98.75 crore. The figures differ slightly.

17 Oct 2025

Sub-division

1 share of ₹10 split into 5 shares of ₹2

Credit Ratings

AgencyRatingOutlookInstrumentDate

CRISIL

B (Issuer Not Cooperating)

Stable

Cash credit ₹7.5 crore; term loan ₹1.5 crore (₹9 crore total)

8 Jul 2026 (also 30 Apr 2025, 29 Feb 2024, 30 Dec 2022)

Brickwork Ratings

——

Bank facilities

Updates 2 Jun 2023, 12 Jun 2024

Moody's / S&P / Fitch

Not rated

———

Analyst Conclusions

Management guidance summary

ItemGuidance
FY2027 revenue₹900–1,000 crore (implies 48–65% YoY growth)
FY2028 revenue+15–20% over FY2027; aspiration of about ₹1,000 crore, with FMCG about 90%
FY2025–FY2029 revenue CAGR30–35%
PAT marginAbout 6% in FY2027; +0.75 to 1.0 pp in FY2028
CapexMinimal capacity capex for 12–18 months
FundingNo new equity raise planned
Margin outlookInput-cost normalisation expected in Q3–Q4 FY27; Q2 FY27 still affected

Implied FY2027 PAT at the guided margins is about ₹54–60 crore, compared with ₹34.98 crore in FY2026. There is no third-party consensus to compare against.

Bull case

  1. Growth is capacity-backed, not speculative. About 20,840 TPM is already installed at 50–55% utilisation, and Q1 FY27 annualises to about ₹1,105 crore. On that run-rate, the FY2027 guide of ₹900–1,000 crore looks conservative.

  2. Operating leverage in FMCG. FMCG EBITDA margin rose about 65 bps YoY to 8.55% even during a cost spike. If inputs normalise, consolidated margins could return to about 10%, which supports the ~6–7% PAT-margin target.

  3. Re-rating toward contract-manufacturing peers. At about 26x trailing P/E and about 17x EV/EBITDA, with 100%+ growth and ROE of about 30%, sustained delivery could attract institutional ownership. DIIs at 3.95% are an early sign.

Bear case

  1. Earnings are not yet cash. FY2026 CFO was −₹34 crore on ₹35 crore of PAT. If working capital keeps rising with revenue, the company may need fresh debt or equity, despite management saying no fundraise is planned.

  2. Disclosure and governance quality. Contradictory segment-mix slides, an unreconciled section table, related-party M&A, CRISIL non-cooperation and a media-driven rumour clarification together justify a governance discount.

  3. Commoditised, price-taking position. B2B soap noodles, detergents and textile job-work give little pricing power. Q1 FY27 already showed margin erosion of about 200 bps from crude-linked inputs, and larger integrated rivals can undercut on price.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhat to watch
Q2 FY27 resultsAbout mid-Nov 2026Revenue run-rate vs. ₹225–250 crore per quarter needed for the guide; margin recovery from 8.18%
H1 FY27 balance sheet and cash flowNov 2026Inventory and receivables build; any turn to positive CFO
Segment-reporting clarityEach quarterA reconciled, consistent textile/FMCG split
Edibles second shiftFY2027Revenue step-up from the Bhilwara edibles plant (about ₹30 crore per quarter now)
Guwahati utilisationFY2027Moving from ₹63.9 crore per quarter toward capacity
Input costs (palm, LABSA, crude)OngoingQ3–Q4 FY27 normalisation as guided
Credit ratingFY2027Whether the company resumes cooperation with CRISIL or obtains a fresh rating
NSE listing statusOngoingConfirmation of the conflicting NSE data
Institutional ownershipQuarterlyDII/FII additions beyond 3.95%
Dividend initiationFY2027 AGMFirst-ever payout as profits scale

Analyst verdict

Sunrakshakk Industries is an unusual case. A thirty-year-old Bhilwara textile job-worker has, in less than two years, turned itself into a B2B FMCG manufacturing platform with more than ₹750 crore of trailing revenue. The headline numbers are striking: revenue rose 3.4x in FY2026, Q1 FY27 PAT grew 131%, reported ROE is about 30%, leverage is modest at 0.25x debt to equity, and there is enough installed headroom that guidance of ₹900–1,000 crore for FY2027 looks achievable without new capital. Management has also improved its investor communication, with quarterly decks, recorded calls and explicit targets that it has so far met or exceeded.

The quality of those earnings is still unproven, however. Operating cash flow turned sharply negative in FY2026 as the business moved from the supplier-financed economics of textile job-work to working-capital-heavy commodity FMCG. Margins are thin, at 8–10% EBITDA, and they depend on palm- and crude-linked inputs the company cannot control. Governance signals are mixed: the platform was built on a related-party acquisition, segment disclosures have contradicted each other, CRISIL's rating carries the "Issuer Not Cooperating" tag, and the board is promoter-dominated with a combined Chair/MD role.

At about 26x trailing earnings and about 6x book, the market is already pricing in a good part of the growth story. In our view the stock is a high-risk, execution-dependent compounding candidate. Three things would improve the investment case: (1) positive operating cash flow by FY2027, (2) reconciled segment reporting, and (3) margin recovery toward 10% as inputs normalise. Failure on cash conversion would be the clearest sign that reported profitability overstates the underlying economics. Stance: cautiously constructive on operations, sceptical on governance and cash quality. Monitor Q2 FY27 (Nov 2026) as the next decision point.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleTenure / notesAgeEducation / prior rolesFY2025 remuneration

Prakash Chand Chhabra

Chairman & Managing Director (Executive)

Long-serving promoter; signed results filings through FY2024. Simply Wall St shows CEO tenure of 2.6 years, which probably reflects a redesignation.

About 60

—

About ₹0.61 crore (₹6.1 million), all salary (Simply Wall St, FY2025)

Tilok Chand Chhabra

Executive Director, Promoter

Part of the 2007 open-offer acquirer group; co-owner per CRISIL

———

Saurabh (Sourabh) Chhabra

Executive Director, Promoter

2007 acquirer group; spokesperson for the Guwahati plant (Jan 2026); bought 1.8 lakh preferential shares (Jul 2025)

———

Aishwarya Tripathi

Independent Non-Executive Director

Recent appointment (date not disclosed)

——

Sitting fees not disclosed

Sandeep Hinger

Independent Non-Executive Director (former)

Formerly with Financial Hospital (finance)

—

Assistant Manager – Finance, Financial Hospital

—

Ashish Kumar Bagrecha

Company Secretary & Compliance Officer

Signs BSE filings since at least 2023

———

CFO

—

Not publicly disclosed in sources reviewed

———

“—” = not publicly disclosed.

Governance Overview

AttributeStatus

Chair/CEO separation

No. Prakash Chand Chhabra is both Chairman and MD.

Executive directors

At least 3, all from the promoter family

Independent directors

At least 1 named (Aishwarya Tripathi); full count not disclosed in sources reviewed

Women on board

At least 1 (Aishwarya Tripathi)

Committees

Audit, Nomination & Remuneration, and Stakeholders' Relationship committees are mandated under the Companies Act and LODR. Composition is not disclosed in sources reviewed.

Internal auditor

Bal Mukund Kabra (died 7 Jan 2026); successor not disclosed

Secretarial auditor

A resignation was disclosed under Regulation 30 (date not shown in the source). Successor not disclosed.

Board & Management Changes

DateChangeContext
2025

Prakash Chand Chhabra joins/redesignated as Executive Director & MD

Blinkx notes a new position in 2025

2025

"A.K. Spintex Limited Appoints Mr. ..."

Owler headline; details truncated

7–8 Jan 2026

Death of the internal auditor disclosed

Regulation 30

Feb 2026

Board and committee changes announced

MarketScreener/S&P CI headline

Not dated

Secretarial auditor resigned

Sharekhan announcement feed

Shareholding Trend

Holder categorySep 2025Dec 2025Mar 2026Jun 2026Sep 2026

Promoters (%)

69.6669.6669.6669.6669.66

DIIs (%)

0.000.000.003.953.95

FIIs (%)

0.000.000.000.000.00

Public (%)

30.3330.3430.3526.3926.38

Number of shareholders

3,7413,5933,6193,7923,947

Competitive Landscape

Competitors by Segment

SegmentCompetitorListed?Relative positioning

Textile processing / Bhilwara cluster

Sangam (India) Ltd

Listed (NSE/BSE)

Much larger integrated yarn, fabric and processing player in Bhilwara

—

RSWM Ltd (LNJ Bhilwara Group)

Listed

Large integrated textile player; owns processing capacity

—

BSL Ltd

Listed

Bhilwara suiting maker with its own processing

—

Banswara Syntex Ltd

Listed

Integrated yarn, fabric and garment maker in Rajasthan; FY2026 revenue ₹1,356 crore

—

Maral Overseas Ltd

Listed

LNJ group; yarn, fabric and processing

—

Numerous unlisted Bhilwara process houses

Unlisted

Direct job-work competitors on price and turnaround

FMCG contract manufacturing

Hindustan Foods Ltd

Listed

India's leading diversified FMCG contract manufacturer; FY2026 total income ₹4,264.7 crore

—

Fena (P) Ltd, RSPL Group

Unlisted

Large detergent and soap manufacturers (own brands plus contract)

—

Jyothy Labs Ltd

Listed

Branded home and personal care; buys or makes soaps and detergents; FY2026 revenue ₹2,944 crore

Soap noodles / oleochemicals

Godrej Industries (Chemicals)

Listed

Major Indian oleochemicals and soap-noodle producer

—

VVF India, 3F Industries, AWL Agri Business (soap noodles)

Mixed

Large-scale noodle suppliers with oils-to-noodles integration

Edibles (savouries/spices)

Bikaji Foods, Gopal Snacks, Prataap Snacks; MDH, Everest (spices)

Mixed

Branded scale players. Sunrakshakk competes at the regional, small-scale end.

Peer Comparison FY2026

Metric (FY2026)SunrakshakkHindustan FoodsJyothy LabsBanswara Syntex

Revenue (INR Cr)

607.754,2512,9441,356

Revenue growth YoY (%)

23719.33.54.9

EBITDA margin (%)

9.668.55—10.5

Operating margin (%)

7.46.413.55.6

Net margin (%)

5.763.511.32.0

Company Snapshot

$70.2M

Revenue

1994

Founded

Bhilwara, India

Headquarters

SWOT Analysis

Strengths

  • Hyper-growth with profits. FY2026 revenue rose 237% to ₹607.75 crore and PAT rose 218% to ₹34.98 crore. Q1 FY27 revenue rose 121% YoY to ₹276.33 crore (company decks).
  • High reported returns. FY2026 ROE about 30% and ROCE 29% (Screener consolidated); three-year average ROE 27%.
  • Low leverage. FY2026 debt of ₹47 crore against equity of ₹185 crore (0.25x); interest cover about 15x.
  • Installed headroom. 20,840 TPM of FMCG capacity at 50–55% utilisation, so revenue can roughly double before major capex (Q1 FY27 concall).
  • Diversified FMCG portfolio across soap noodles, soaps, toothpaste, detergents, cosmetics, home care and edibles, with no single section above about 32% of Q1 FY27 FMCG revenue (Roorkee noodles ₹87.62 crore of ₹250.10 crore).
  • Promoter commitment. Promoters participated in the ₹840 preferential issue (Saurabh Chhabra bought 1.8 lakh shares); promoter holding is 69.66% with no pledge.
  • Improving FMCG margin. FMCG EBITDA margin rose to 8.55% in Q1 FY27 from 7.90% in Q1 FY26.

Weaknesses

  • Negative operating cash flow. FY2026 consolidated CFO was −₹34 crore (standalone −₹66 crore) against EBITDA of ₹58.7 crore; FCF was −₹92 crore.
  • Working-capital blow-out. CCC moved from −40 to +31 days; standalone working-capital days rose from 22 to 161 (Screener).
  • Inconsistent segment disclosure. The Q4 FY26 deck's mix slide (83% textile) conflicts with the Annual Report (82% FMCG), and its section table does not reconcile to total revenue (₹170.8 crore vs. ₹197.59 crore).
  • Thin margin structure. Consolidated EBITDA margin fell from 14.24% (FY2025) to 9.66% (FY2026) and 8.18% (Q1 FY27).
  • Weak credit-rating engagement. CRISIL rating is B/Stable "Issuer Not Cooperating" continuously since at least December 2022 (CRISIL, 8 Jul 2026).
  • Concentrated governance. Combined Chairman/MD role; three promoter-family executive directors; about 1.5-year average board tenure.
  • No dividend despite repeated profits (0% payout in every year since at least FY2015).

Opportunities

  • FY2027 guidance of ₹900–1,000 crore revenue implies 48–65% growth over FY2026 (Q1 FY27 concall).
  • Second edibles shift at Bhilwara, with no new capex needed.
  • Guwahati ramp-up (₹63.9 crore in Q1 FY27 from a January 2026 start) to serve eastern and North-East demand.
  • Outsourcing tailwind in Indian FMCG, as the scale-up of B2B makers like Hindustan Foods (FY2026 total income up 17%) shows.
  • Margin recovery if crude and palm-linked inputs normalise; management expects this by Q3–Q4 FY27.
  • Possible future B2C brand-building in edibles (Sun Papsi, Majedar Bhujia, Rasoi Tadaka Masala), from which the company is currently absent.

Threats

  • Input-cost volatility. LABSA pricing is linked to international markets, and dyes, chemicals and boiler fuel have all risen (Q1 FY27 concall).
  • Customer bargaining power in B2B contract manufacturing, plus undisclosed concentration.
  • Larger competitors with integration and scale (Hindustan Foods about 7x revenue; oleochemical majors in noodles).
  • Related-party and governance scrutiny. SAPPL was acquired from promoter interests, and a regional media article prompted a Regulation 30(11) rumour clarification.
  • Valuation risk. The stock trades at about 26x trailing P/E and about 6x book (Screener). The ten-year price CAGR of 41% leaves little room for execution misses.
  • Liquidity and funding risk if CFO stays negative while working capital grows with revenue.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
25 Apr 2025MCA issues a fresh certificate: A.K. Spintex becomes Sunrakshakk Industries India LtdFormal identity change
30 Apr 2025CRISIL maintains B/Stable (Issuer Not Cooperating)Signals weak disclosure discipline toward lenders and raters
14 May 2025Company expects about ₹98.75 crore from a group of investors (preferential)Growth capital
15 May 2025BSE in-principle approval for the preferential issueRegulatory clearance
22 May 2025Board meeting; renaming press release; scrip ID changed to SUNRAKSHAKRebrand completed
30 May 2025FY2025 results (revenue ₹180.16 crore, PAT ₹11.01 crore); 11,69,600 preferential shares allottedFirst year with FMCG contribution
Jun 2025Investor presentation (Q4 FY25) filed; quarterly IR programme startsBetter communication
17–18 Jul 2025Listing approval received for preferential sharesShares can list; trading approval followed
30 Jul 2025PIT/SAST: Saurabh Chhabra bought 1.8 lakh shares at ₹840; Tilok Chand Chhabra sold 60,000Promoter participation in the raise
Aug 2025Q1 FY26: revenue ₹125.24 crore, PAT ₹6.52 croreScale-up begins
3 Sep 20251:5 stock split announcedLiquidity measure
Sep 2025Bhilwara edibles plant fully operationalNew edibles vertical
17 Oct 2025Split effective; new ISIN INE671K01027. The share was about ₹1,265 before the split, up about 325% over one year.Price momentum peak
14 Nov 2025Q2 FY26 results (revenue ₹120.97 crore) and deck; ₹1,000 crore FY2028 target; 30–35% CAGR guideMedium-term targets set
8 Jan 2026Guwahati FMCG plant starts commercial operations (3,160 TPM)Third FMCG location
8 Jan 2026Death of the internal auditor disclosedGovernance continuity
9 Jan 2026Stock at about ₹207.50 (market cap about ₹629 crore)Post-split re-rating base
14 Feb 2026Q3 FY26: consolidated revenue ₹163.95 crore (standalone ₹51.62 crore); PAT about ₹9.4 croreGuwahati and edibles contribute
Feb 2026First recorded earnings call; board and committee changes announcedIR deepening
23 Feb 2026Website migrated to sunrakshakk.comRebrand housekeeping
Late May 2026FY2026 results: revenue ₹607.75 crore (+237%), EBITDA ₹58.69 crore, PAT ₹34.98 croreTransformation year
Jun 2026Q4 FY26 concall; deck segment-mix labels inconsistentDisclosure-quality concern
Jun 2026 quarterUnnamed DIIs appear with a 3.95% stakeFirst institutional holding
8 Jul 2026CRISIL continues B/Stable (INC); notes non-cooperation since 21 May 2026Rating hygiene still weak
Q1 FY27Roorkee soap line (+1,700 TPM) commissionedCapacity reaches 20,840 TPM
Mid-Aug 2026Q1 FY27: revenue ₹276.33 crore (+121% YoY), PAT ₹15.04 crore (+131%), EBITDA margin down to 8.18%Record quarter, margin pressure
17 Aug 2026Q1 FY27 concall: FY2027 revenue guide ₹900–1,000 crore; utilisation 50–55%; B2B only; no fundraiseGuidance raised
4 Sep 2026Stock about ₹371.80; 52-week high ₹394Near highs
30 Sep – 1 Oct 2026AGM held; scrutinizer's report filedAnnual compliance
12 Oct 2026Regulation 74(5) certificate for Q2 FY27Routine; Q2 FY27 results due around mid-Nov 2026

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment (FY2024–FY2026): Total revenue from operations rose from INR 1,170 Mn in FY2024 to INR 6,077.5 Mn in FY2026.
Sunrakshakk Industries India Limited — Revenue by Segment (FY2024–FY2026)
Series (INR Mn)FY2024FY2025FY2026
Total revenue from operations1,1701,801.66,077.5
Textile processing revenue1,1701,0451,090
FMCG incl. intermediates and edibles revenue07574,980

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. BSE Ltd: company announcements and annual reports for scrip 539300 (FY2018, FY2023, FY2024, FY2025, FY2026); results filings dated 30 May 2023, 30 May 2024, 13 Nov 2024; SAPPL acquisition disclosure; name-change certificate (25 Apr 2025); press release (22 May 2025); preferential in-principle approval (15 May 2025); Q2 FY26 investor presentations (14 Nov 2025); website update (23 Feb 2026); FY2026 Annual Report chairman's letter.
  2. CRISIL Ratings: Rating Rationale for Sunrakshakk Industries India Ltd, 8 July 2026.
  3. SEBI: A.K. Spintex Letter of Offer (Dec 2007) and Post-Offer Public Announcement.
  4. Screener.in: consolidated and standalone financials, ratios, shareholding and announcements for Sunrakshakk Industries India Ltd (data as of 16–18 Oct 2026).
  5. Multibagg AI: summaries of the Q4 FY26 deck (1 Jun 2026) and the Q1 FY27 deck and concall (14 Aug 2026).
  6. IIFL / IndiaInfoline: company summary, EGM records, split notices, FY2025 Directors' Report.
  7. The Machine Maker; Accord Fintech / Investment Guru India: Guwahati plant commissioning (Jan 2026).
  8. Simply Wall St; Blinkx; MarketScreener: management, board and compensation data.
  9. Trendlyne: SEBI PIT/SAST disclosures (Jul 2025).
  10. Google Finance; Equitymaster; 5paisa; Upstox; Nirmal Bang / Jhaveri (Capitaline): price, listing and ISIN data.
  11. StockAnalysis.com; Hindustan Foods press release (FY2026); Jyothy Labs FY2026 results; Anand Rathi / Screener (Banswara Syntex): peer financials.

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.